Guillaume Direz

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey

Raphaèle Séror, Christophe Richez, Christelle Sordet et al. · Lara D. Veeken · 2013 · 138 citations

New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases

Daniel Wendling, Julien Paccou, Jean‐Marie Berthelot et al. · Seminars in Arthritis and Rheumatism · 2011 · 136 citations

Inflammation, Rheumatology, Rheumatoid Disorder +9

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy

Valérie Devauchelle‐Pensec, Guillermo Carvajal Alegria, Emmanuelle Dernis et al. · JAMA · 2022 · 103 citations · Full text

Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials

Florence Delestre, Pierre Charles, Alexandre Karras et al. · Annals of the Rheumatic Diseases · 2023 · 39 citations · Full text